Quotes Northwest Biotherapeutics, Inc. Börse Stuttgart
Stocks
NBYB
US66737P6007
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1340 EUR | -9.46% |
|
-13.55% | -34.95% |
Quotes 5-day view: Northwest Biotherapeutics, Inc.
Delayed Quote Börse Stuttgart
| 2026-07-27 | 2026-07-28 | 2026-07-29 | 2026-07-30 | 2026-07-31 | |
|---|---|---|---|---|---|
| Last | €0.1550 | €0.1500 | €0.1500 | €0.1480 | €0.1340 |
| Volume | 1,150 | 23,100 | 27,000 | 1,000 | 54,005 |
| Change | -.--% | -3.23% | -.--% | -1.33% | -9.46% |
| Opening | €0.1550 | €0.1550 | €0.1500 | €0.1480 | €0.1480 |
| High | €0.1600 | €0.1580 | €0.1500 | €0.1580 | €0.1510 |
| Low | €0.1550 | €0.1500 | €0.1500 | €0.1480 | €0.1300 |
Performance
| 1 day | -9.46% | ||
| 1 week | -13.55% | ||
| 1 month | -7.59% | ||
| 3 months | -25.56% | ||
| 6 months | -46.40% | ||
| Current year | -34.95% | ||
| 1 year | -41.23% | ||
| 3 years | -72.65% | ||
| 5 years | -87.36% |
Volumes
marketsDaily volume
54,005
Estimated daily volume
54,005
Avg. Volume 20 sessions
29,527
Daily volume ratio
1.83
Avg. Volume 20 sessions
3,956.62
Avg. Volume 20 sessions USD
4,561.19
Record volume 1
314,490
Record volume 2
208,865
Record volume 3
200,000
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
276,844,210
Market Cap (USD)
276,844,210
Net sales (USD)
0
Number of employees
105
Sales / Employee (USD)
0
Free-Float
95.04 %
Free-Float capitalization (EUR)
296,810,924
Free-Float capitalization (USD)
258,017,736
Average Daily Capital Traded
0%
Indicators
Moving average 5 days
0.1474
Moving average 20 days
0.153
Moving average 50 days
0.1654
Moving average 100 days
0.1723
Price spread / (MMA5)
+10.00%
Price spread / (MMA20)
+14.18%
Price spread / (MMA50)
+23.43%
Price spread / (MMA100)
+28.58%
RSI 9 days
45.72
RSI 14 days
45.55
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -9.46% | -13.55% | -41.23% | -72.65% | 277M | |
| +2.35% | +2.74% | +33.41% | +79.20% | 56.54B | |
| -0.21% | -7.38% | +25.34% | +63.02% | 53.6B | |
| -2.44% | +1.40% | -15.74% | -16.80% | 22.91B | |
| -2.85% | -7.78% | -8.09% | +346.36% | 21.37B | |
| +2.49% | -0.92% | +20.31% | -12.15% | 20.27B | |
| +0.79% | -1.06% | +29.29% | -33.32% | 17.56B | |
| +0.58% | -5.88% | +16.30% | +540.37% | 14.75B | |
| -5.25% | -4.23% | +46.41% | +169.05% | 13.33B | |
| +3.41% | -6.61% | +163.08% | +280.43% | 13.53B | |
| Average | -1.06% | -3.79% | +26.91% | +134.35% | 23.41B | |
| Weighted average by Cap. | +0.22% | -2.96% | +28.59% | +119.75% |
Historical Quotes: Northwest Biotherapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 0.13 |  | 0.16 |
| 1 month | 0.1 | | 0.19 |
| Current year | 0.1 | | 0.38 |
| 1 year | 0.1 | | 0.38 |
| 3 years | 0.1 | | 1.02 |
| 5 years | 0.1 | | 2.18 |
| 10 years | 0.1 | | 2.18 |
Monthly variations
Annual variations
| 2026 | -34.95% | ||
| 2025 | -32.68% | ||
| 2024 | -52.56% | ||
| 2023 | -16.99% | ||
| 2022 | +32.82% | ||
| 2021 | -53.94% | ||
| 2020 | +609.50% | ||
| 2019 | +4.68% | ||
| 2018 | -.--% | ||
| 2017 | -46.39% |
- Stock Market
- Stocks
- NWBO Stock
- NBYB Stock
- Quotes Northwest Biotherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
